4 FDA actions
FINTEPLA (FENFLURAMINE)
UCB INC
KYGEVVI (DOXECITINE AND DOXRIBTIMINE)
BIMZELX (BIMEKIZUMAB)
KEPPRA (LEVETIRACETAM)